/PRNewswire/ Berlin-based digital health company Fosanis, the developer of Mika, Germany s first prescription DTx for all oncological indications, closed a.
New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company Fosanis to broaden patient access of Mika - an app-based DTx platform empowering